Anti-SARS-CoV-2 antibody among SARS-CoV-2 vaccinated vs post-infected blood donors in a tertiary hospital, Bangkok, Thailand

SARS-CoV-2 virus infection has imposed a significant healthcare burden globally. To contain its spread and decrease infection-related mortality, several vaccines have been deployed worldwide in the past 3 years. We conducted a cross-sectional seroprevalence study to assess the immune response agains...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 18; no. 5; p. e0285737
Main Authors Permpikul, Parichart, Tongyoo, Surat, Chaimayo, Chutikarn, Kanpai, Prapan, Virat, Jitmanee, Virat, Sutasinee, Chuchaaim, Jaratsri, Thongput, Anchalee, Bhatnagar, Sonu
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 18.05.2023
Public Library of Science (PLoS)
Subjects
Adult
Analysis
Antibodies
Antibodies, Viral
Biology and Life Sciences
Blood
Blood & organ donations
Blood Donors
Coronaviruses
COVID-19 - prevention & control
COVID-19 vaccines
Cross-Sectional Studies
Disease transmission
Evaluation
Female
Health aspects
Humans
Immune response
Immune system
Immunoglobulin G
Infection
Infections
Laboratories
Male
Medical research
Medicine and Health Sciences
Medicine, Experimental
Middle Aged
Mortality
Multivariate analysis
Nucleocapsids
Pandemics
Pharmaceutical industry
Proteins
SARS-CoV-2
Seroepidemiologic Studies
Serology
Severe acute respiratory syndrome coronavirus 2
Spike protein
Tertiary
Tertiary Care Centers
Thailand
Thailand - epidemiology
United Kingdom
United States
Vaccination
Vaccines
Variables
Viral antibodies
Viral diseases
Virus diseases
Viruses
Thailand
United States
United Kingdom
Bangkok Thailand
Online AccessGet full text

Cover

Abstract SARS-CoV-2 virus infection has imposed a significant healthcare burden globally. To contain its spread and decrease infection-related mortality, several vaccines have been deployed worldwide in the past 3 years. We conducted a cross-sectional seroprevalence study to assess the immune response against the virus among blood donors at a tertiary care hospital, Bangkok, Thailand. From December 2021 to March 2022, total of 1,520 participants were enrolled, and their past history of SARS-CoV-2 infection and vaccination was recorded. Two serology test, namely, quantitative IgG spike protein (IgGSP) and qualitative IgG nucleocapsid antibody (IgGNC) were performed. The median age of study participants was 40 years (IQR 30-48) and 833 (54.8%) were men. Vaccine uptake was reported in 1,500 donors (98.7%) and 84 (5.5%) reported the past infection history. IgGNC was detected in 46/84 donors with the past infection history (54.8%) and in 36 out of the rest 1,436 (2.5%) with no past history. IgGSP positivity was observed in 1484 donors (97.6%). When compared to unvaccinated donors (n = 20), IgGSP level was higher in the donors who had received one vaccine dose (p< 0.001) and these antibody levels increased significantly among those with 3rd and 4th vaccine doses. Factors associated with low IgGSP (lowest quartile) by multivariate analysis included: no past infection history, homologous vaccination, < 3 vaccine doses, and > 90 days duration since last vaccination. In conclusion, vaccine uptake among our study donors was high (98.7%) and IgGSP antibody was observed in nearly all the vaccinated donors (97.6%). Previous SARS-CoV-2 infection, use of heterologous vaccination, vaccines ≥ 3 doses, and duration of the last vaccination >90 days affected IgGSP levels. Use of serological assays were found beneficial in the evaluation and differentiation of immune response to vaccination, and natural infection including the identification of previous asymptomatic infections.
AbstractList SARS-CoV-2 virus infection has imposed a significant healthcare burden globally. To contain its spread and decrease infection-related mortality, several vaccines have been deployed worldwide in the past 3 years. We conducted a cross-sectional seroprevalence study to assess the immune response against the virus among blood donors at a tertiary care hospital, Bangkok, Thailand. From December 2021 to March 2022, total of 1,520 participants were enrolled, and their past history of SARS-CoV-2 infection and vaccination was recorded. Two serology test, namely, quantitative IgG spike protein (IgGSP) and qualitative IgG nucleocapsid antibody (IgGNC) were performed. The median age of study participants was 40 years (IQR 30-48) and 833 (54.8%) were men. Vaccine uptake was reported in 1,500 donors (98.7%) and 84 (5.5%) reported the past infection history. IgGNC was detected in 46/84 donors with the past infection history (54.8%) and in 36 out of the rest 1,436 (2.5%) with no past history. IgGSP positivity was observed in 1484 donors (97.6%). When compared to unvaccinated donors (n = 20), IgGSP level was higher in the donors who had received one vaccine dose (p< 0.001) and these antibody levels increased significantly among those with 3rd and 4th vaccine doses. Factors associated with low IgGSP (lowest quartile) by multivariate analysis included: no past infection history, homologous vaccination, < 3 vaccine doses, and > 90 days duration since last vaccination. In conclusion, vaccine uptake among our study donors was high (98.7%) and IgGSP antibody was observed in nearly all the vaccinated donors (97.6%). Previous SARS-CoV-2 infection, use of heterologous vaccination, vaccines ≥ 3 doses, and duration of the last vaccination >90 days affected IgGSP levels. Use of serological assays were found beneficial in the evaluation and differentiation of immune response to vaccination, and natural infection including the identification of previous asymptomatic infections.
SARS-CoV-2 virus infection has imposed a significant healthcare burden globally. To contain its spread and decrease infection-related mortality, several vaccines have been deployed worldwide in the past 3 years. We conducted a cross-sectional seroprevalence study to assess the immune response against the virus among blood donors at a tertiary care hospital, Bangkok, Thailand. From December 2021 to March 2022, total of 1,520 participants were enrolled, and their past history of SARS-CoV-2 infection and vaccination was recorded. Two serology test, namely, quantitative IgG spike protein (IgG SP ) and qualitative IgG nucleocapsid antibody (IgG NC ) were performed. The median age of study participants was 40 years (IQR 30–48) and 833 (54.8%) were men. Vaccine uptake was reported in 1,500 donors (98.7%) and 84 (5.5%) reported the past infection history. IgG NC was detected in 46/84 donors with the past infection history (54.8%) and in 36 out of the rest 1,436 (2.5%) with no past history. IgG SP positivity was observed in 1484 donors (97.6%). When compared to unvaccinated donors (n = 20), IgG SP level was higher in the donors who had received one vaccine dose (p< 0.001) and these antibody levels increased significantly among those with 3 rd and 4 th vaccine doses. Factors associated with low IgG SP (lowest quartile) by multivariate analysis included: no past infection history, homologous vaccination, < 3 vaccine doses, and > 90 days duration since last vaccination. In conclusion, vaccine uptake among our study donors was high (98.7%) and IgG SP antibody was observed in nearly all the vaccinated donors (97.6%). Previous SARS-CoV-2 infection, use of heterologous vaccination, vaccines ≥ 3 doses, and duration of the last vaccination >90 days affected IgG SP levels. Use of serological assays were found beneficial in the evaluation and differentiation of immune response to vaccination, and natural infection including the identification of previous asymptomatic infections.
SARS-CoV-2 virus infection has imposed a significant healthcare burden globally. To contain its spread and decrease infection-related mortality, several vaccines have been deployed worldwide in the past 3 years. We conducted a cross-sectional seroprevalence study to assess the immune response against the virus among blood donors at a tertiary care hospital, Bangkok, Thailand. From December 2021 to March 2022, total of 1,520 participants were enrolled, and their past history of SARS-CoV-2 infection and vaccination was recorded. Two serology test, namely, quantitative IgG spike protein (IgG SP ) and qualitative IgG nucleocapsid antibody (IgG NC ) were performed. The median age of study participants was 40 years (IQR 30–48) and 833 (54.8%) were men. Vaccine uptake was reported in 1,500 donors (98.7%) and 84 (5.5%) reported the past infection history. IgG NC was detected in 46/84 donors with the past infection history (54.8%) and in 36 out of the rest 1,436 (2.5%) with no past history. IgG SP positivity was observed in 1484 donors (97.6%). When compared to unvaccinated donors (n = 20), IgG SP level was higher in the donors who had received one vaccine dose (p< 0.001) and these antibody levels increased significantly among those with 3 rd and 4 th vaccine doses. Factors associated with low IgG SP (lowest quartile) by multivariate analysis included: no past infection history, homologous vaccination, < 3 vaccine doses, and > 90 days duration since last vaccination. In conclusion, vaccine uptake among our study donors was high (98.7%) and IgG SP antibody was observed in nearly all the vaccinated donors (97.6%). Previous SARS-CoV-2 infection, use of heterologous vaccination, vaccines ≥ 3 doses, and duration of the last vaccination >90 days affected IgG SP levels. Use of serological assays were found beneficial in the evaluation and differentiation of immune response to vaccination, and natural infection including the identification of previous asymptomatic infections.
SARS-CoV-2 virus infection has imposed a significant healthcare burden globally. To contain its spread and decrease infection-related mortality, several vaccines have been deployed worldwide in the past 3 years. We conducted a cross-sectional seroprevalence study to assess the immune response against the virus among blood donors at a tertiary care hospital, Bangkok, Thailand. From December 2021 to March 2022, total of 1,520 participants were enrolled, and their past history of SARS-CoV-2 infection and vaccination was recorded. Two serology test, namely, quantitative IgG spike protein (IgG.sub.SP) and qualitative IgG nucleocapsid antibody (IgG.sub.NC) were performed. The median age of study participants was 40 years (IQR 30-48) and 833 (54.8%) were men. Vaccine uptake was reported in 1,500 donors (98.7%) and 84 (5.5%) reported the past infection history. IgG.sub.NC was detected in 46/84 donors with the past infection history (54.8%) and in 36 out of the rest 1,436 (2.5%) with no past history. IgG.sub.SP positivity was observed in 1484 donors (97.6%). When compared to unvaccinated donors (n = 20), IgG.sub.SP level was higher in the donors who had received one vaccine dose (p< 0.001) and these antibody levels increased significantly among those with 3.sup.rd and 4.sup.th vaccine doses. Factors associated with low IgG.sub.SP (lowest quartile) by multivariate analysis included: no past infection history, homologous vaccination, 90 days duration since last vaccination. In conclusion, vaccine uptake among our study donors was high (98.7%) and IgG.sub.SP antibody was observed in nearly all the vaccinated donors (97.6%). Previous SARS-CoV-2 infection, use of heterologous vaccination, vaccines [greater than or equal to] 3 doses, and duration of the last vaccination >90 days affected IgG.sub.SP levels. Use of serological assays were found beneficial in the evaluation and differentiation of immune response to vaccination, and natural infection including the identification of previous asymptomatic infections.
Audience Academic
Author Chaimayo, Chutikarn
Virat, Jitmanee
Tongyoo, Surat
Chuchaaim, Jaratsri
Kanpai, Prapan
Thongput, Anchalee
Bhatnagar, Sonu
Permpikul, Parichart
Virat, Sutasinee
AuthorAffiliation 3 Department of Microbiology, Faculty of Medicine, Siriraj Hospital Mahidol University, Bangkok, Thailand
4 Scientific Affairs, Abbott Laboratories Singapore Pte Ltd., Singapore, Singapore
University of Ilorin, NIGERIA
1 Department of Transfusion Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
2 Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
AuthorAffiliation_xml – name: 4 Scientific Affairs, Abbott Laboratories Singapore Pte Ltd., Singapore, Singapore
– name: University of Ilorin, NIGERIA
– name: 1 Department of Transfusion Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
– name: 2 Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
– name: 3 Department of Microbiology, Faculty of Medicine, Siriraj Hospital Mahidol University, Bangkok, Thailand
Author_xml – sequence: 1
  givenname: Parichart
  orcidid: 0000-0003-3318-1744
  surname: Permpikul
  fullname: Permpikul, Parichart
  organization: Department of Transfusion Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
– sequence: 2
  givenname: Surat
  surname: Tongyoo
  fullname: Tongyoo, Surat
  organization: Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
– sequence: 3
  givenname: Chutikarn
  orcidid: 0000-0003-4603-7012
  surname: Chaimayo
  fullname: Chaimayo, Chutikarn
  organization: Department of Microbiology, Faculty of Medicine, Siriraj Hospital Mahidol University, Bangkok, Thailand
– sequence: 4
  givenname: Prapan
  surname: Kanpai
  fullname: Kanpai, Prapan
  organization: Department of Transfusion Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
– sequence: 5
  givenname: Jitmanee
  surname: Virat
  fullname: Virat, Jitmanee
  organization: Department of Transfusion Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
– sequence: 6
  givenname: Sutasinee
  surname: Virat
  fullname: Virat, Sutasinee
  organization: Department of Transfusion Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
– sequence: 7
  givenname: Jaratsri
  surname: Chuchaaim
  fullname: Chuchaaim, Jaratsri
  organization: Department of Transfusion Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
– sequence: 8
  givenname: Anchalee
  surname: Thongput
  fullname: Thongput, Anchalee
  organization: Department of Microbiology, Faculty of Medicine, Siriraj Hospital Mahidol University, Bangkok, Thailand
– sequence: 9
  givenname: Sonu
  orcidid: 0000-0003-3155-5829
  surname: Bhatnagar
  fullname: Bhatnagar, Sonu
  organization: Scientific Affairs, Abbott Laboratories Singapore Pte Ltd., Singapore, Singapore
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37200273$$D View this record in MEDLINE/PubMed
BookMark eNqNk1tr2zAUx83oWC_bNxibYTA2qDPdLFlPIwu7BAqFpuurkCU5UepImaWEFfbhJzduSUYfhh4kHf3OX-cc6ZxmR847k2WvIRhBzOCnpd90TrajdTKPAKpKhtmz7ARyjAqKAD7aWx9npyEsAShxRemL7BgzBABi-CT7M3bRFrPx1ayY-JsC5TLta6_vcrnybp7vnWylUtbJaHS-Dfnah1hY1xjVG-rWe51r73wXcutymUfTRSu7u3zhw9pG2Z7nX6Sb3_rb8_x6IW0rnX6ZPW9kG8yrYT7Lfn77ej35UVxcfp9OxheFogTFoqor0xjQYIZrqTlgCsOGMEkaCkDDqQakamBdasJRRXlFJGpqzBgnhFJpID7L3u50160PYihcEKiCJcIMlD0x3RHay6VYd3aVQhdeWnFv8N1cyJSPao1AhOrKcFVXHJKq5nWJFaGEYa4k05Akrc_DbZt6ZbQyLnayPRA9PHF2IeZ-KyCAnHCOksKHQaHzvzYmRLGyQZk21cz4zX3glFGMK5DQd_-gT6c3UHOZMkiv5tPFqhcVY0Y4IyVkfeCjJ6g0tFlZlb5ZY5P9wOHjgUNiovkd53ITgpjOrv6fvbw5ZN_vsQsj27gIvt1E6104BMkOVJ0PoTPNY5UhEH2XPFRD9F0ihi5Jbm_2X-jR6aEt8F9yBgw-
Cites_doi 10.1126/science.abm3425
10.1136/postgradmedj-2021-140654
10.1001/jama.2022.17876
10.1056/NEJMra2206573
10.1056/NEJMoa2116414
10.1056/NEJMoa2114114
10.1007/s15010-021-01651-4
10.1371/journal.pone.0263316
10.1016/S0140-6736(22)00094-0
10.1080/21645515.2022.2091865
10.1016/j.diagmicrobio.2022.115659
10.1016/j.lanepe.2021.100249
10.1136/bmjopen-2020-046676
10.1056/NEJMoa2200674
10.1371/journal.pone.0263127
10.1093/cid/ciaa1116
10.1016/j.jcv.2021.104765
10.1016/j.ejim.2022.11.009
10.1056/NEJMc2201821
10.1038/s41541-021-00396-3
10.1128/spectrum.01315-22
10.1038/s41591-021-01325-6
ContentType Journal Article
Copyright Copyright: © 2023 Permpikul et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
COPYRIGHT 2023 Public Library of Science
2023 Permpikul et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 Permpikul et al 2023 Permpikul et al
2023 Permpikul et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: Copyright: © 2023 Permpikul et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
– notice: COPYRIGHT 2023 Public Library of Science
– notice: 2023 Permpikul et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 Permpikul et al 2023 Permpikul et al
– notice: 2023 Permpikul et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
COVID
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0285737
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Opposing Viewpoints Resource Center
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest Central
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
Coronavirus Research Database
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
ProQuest Biological Science Collection
Agriculture Science Database
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
Open Access: DOAJ - Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Biological Science Collection
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
Coronavirus Research Database
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
Technology Collection
Technology Research Database
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE



Agricultural Science Database

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate Anti-SARS-CoV-2 antibody in Thai blood donors
EISSN 1932-6203
Editor Kolawole, Olatunji Matthew
Editor_xml – sequence: 1
  givenname: Olatunji Matthew
  surname: Kolawole
  fullname: Kolawole, Olatunji Matthew
EndPage e0285737
ExternalDocumentID 2815237051
oai_doaj_org_article_246d8e9cb89148b9b53c464739ca7d14
A749745174
10_1371_journal_pone_0285737
37200273
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Thailand
United States
United Kingdom
Bangkok Thailand
GeographicLocations_xml – name: Thailand
– name: United Kingdom
– name: United States
– name: Bangkok Thailand
GrantInformation_xml – fundername: ;
GroupedDBID ---
123
29O
2WC
3V.
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BBORY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CGR
CS3
CUY
CVF
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
ECM
EIF
EMOBN
ESTFP
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
IOV
IPNFZ
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
NPM
O5R
O5S
OK1
P2P
P62
PATMY
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RIG
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
AAYXX
AFPKN
CITATION
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
COVID
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PQEST
PQUKI
PRINS
RC3
7X8
5PM
AAPBV
ABPTK
N95
ID FETCH-LOGICAL-c642t-8b8efe0f373bad907c31f47a4f600f96d048f1b5d49286984a2fb37794466ae13
IEDL.DBID RPM
ISSN 1932-6203
IngestDate Sun Jul 02 11:04:14 EDT 2023
Tue Oct 22 15:15:46 EDT 2024
Tue Sep 17 21:32:21 EDT 2024
Fri Oct 25 09:34:37 EDT 2024
Thu Oct 10 17:37:36 EDT 2024
Thu Feb 22 23:53:41 EST 2024
Fri Feb 02 04:29:24 EST 2024
Sat Sep 28 21:09:06 EDT 2024
Sat Sep 28 21:37:30 EDT 2024
Tue Aug 20 22:02:28 EDT 2024
Fri Aug 23 03:08:00 EDT 2024
Wed Oct 16 00:38:36 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License Copyright: © 2023 Permpikul et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c642t-8b8efe0f373bad907c31f47a4f600f96d048f1b5d49286984a2fb37794466ae13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: Parichart Permpikul has no affiliation with Abbott Laboratories Pte Ltd. Parichart Permpikul received honoraria for academic lecture from Abbott Laboratories. None of other authors have any competing interests except Sonu Bhatnagar is employee and shareholder of Abbott Diagnostic. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
ORCID 0000-0003-3318-1744
0000-0003-3155-5829
0000-0003-4603-7012
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194992/
PMID 37200273
PQID 2815237051
PQPubID 1436336
PageCount e0285737
ParticipantIDs plos_journals_2815237051
doaj_primary_oai_doaj_org_article_246d8e9cb89148b9b53c464739ca7d14
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10194992
proquest_miscellaneous_2816763380
proquest_journals_2815237051
gale_infotracmisc_A749745174
gale_infotracacademiconefile_A749745174
gale_incontextgauss_ISR_A749745174
gale_incontextgauss_IOV_A749745174
gale_healthsolutions_A749745174
crossref_primary_10_1371_journal_pone_0285737
pubmed_primary_37200273
PublicationCentury 2000
PublicationDate 2023-05-18
PublicationDateYYYYMMDD 2023-05-18
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-05-18
  day: 18
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2023
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References S Niyomnaitham (pone.0285737.ref020) 2022; 18
H Alexopoulos (pone.0285737.ref009) 2023; 107
H Lerdsamran (pone.0285737.ref014) 2022; 17
S Takalay (pone.0285737.ref015) 2022; 17
P Nordström (pone.0285737.ref007) 2021; 11
SA Costa Clemens (pone.0285737.ref006) 2022; 399
DY Lin (pone.0285737.ref023) 2022; 328
pone.0285737.ref018
T Nopsopon (pone.0285737.ref016) 2021; 11
SK Yoon (pone.0285737.ref021) 2022; 386
MP Busch (pone.0285737.ref017) 2021; 72
PB Gilbert (pone.0285737.ref027) 2022; 375
HR Choudhary (pone.0285737.ref012) 2021; 49
J Van Elslande (pone.0285737.ref028) 2021; 136
B Grunau (pone.0285737.ref010) 2022; 10
JE Ebinger (pone.0285737.ref019) 2021; 27
DH Barouch (pone.0285737.ref026) 2022; 387
H Chemaitelly (pone.0285737.ref025) 2021; 385
Z Zhang (pone.0285737.ref004) 2022; 13
R Assis (pone.0285737.ref008) 2021; 6
AI Francis (pone.0285737.ref003) 2022; 98
JL Bayart (pone.0285737.ref024) 2021; 9
pone.0285737.ref005
J Van Elslande (pone.0285737.ref011) 2022; 103
ED Moreira (pone.0285737.ref022) 2022; 386
pone.0285737.ref001
pone.0285737.ref002
RL Atmar (pone.0285737.ref013) 2022; 386
References_xml – ident: pone.0285737.ref002
– volume: 375
  start-page: 43
  issue: 6576
  year: 2022
  ident: pone.0285737.ref027
  article-title: Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
  publication-title: Science
  doi: 10.1126/science.abm3425
  contributor:
    fullname: PB Gilbert
– volume: 98
  start-page: 389I
  issue: 1159
  year: 2022
  ident: pone.0285737.ref003
  article-title: Review of COVID-19 vaccine subtypes, efficacy and geographical distributions
  publication-title: Postgraduate Medical Journal
  doi: 10.1136/postgradmedj-2021-140654
  contributor:
    fullname: AI Francis
– volume: 328
  start-page: 1415
  issue: 14
  year: 2022
  ident: pone.0285737.ref023
  article-title: Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes
  publication-title: Jama
  doi: 10.1001/jama.2022.17876
  contributor:
    fullname: DY Lin
– volume: 387
  start-page: 1011
  issue: 11
  year: 2022
  ident: pone.0285737.ref026
  article-title: Covid-19 Vaccines—Immunity, Variants, Boosters
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJMra2206573
  contributor:
    fullname: DH Barouch
– volume: 386
  start-page: 1046
  issue: 11
  year: 2022
  ident: pone.0285737.ref013
  article-title: Homologous and Heterologous Covid-19 Booster Vaccinations
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJMoa2116414
  contributor:
    fullname: RL Atmar
– volume: 9
  issue: 10
  year: 2021
  ident: pone.0285737.ref024
  article-title: Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers
  publication-title: Vaccines (Basel)
  contributor:
    fullname: JL Bayart
– volume: 385
  start-page: e83I
  issue: 24
  year: 2021
  ident: pone.0285737.ref025
  article-title: Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJMoa2114114
  contributor:
    fullname: H Chemaitelly
– ident: pone.0285737.ref018
– volume: 13
  year: 2022
  ident: pone.0285737.ref004
  article-title: Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
  publication-title: Frontiers in Immunology
  contributor:
    fullname: Z Zhang
– volume: 49
  start-page: 1045
  issue: 5
  year: 2021
  ident: pone.0285737.ref012
  article-title: IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
  publication-title: Infection
  doi: 10.1007/s15010-021-01651-4
  contributor:
    fullname: HR Choudhary
– ident: pone.0285737.ref001
– volume: 17
  start-page: e0263316I
  issue: 4
  year: 2022
  ident: pone.0285737.ref014
  article-title: Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0263316
  contributor:
    fullname: H Lerdsamran
– volume: 399
  start-page: 521
  issue: 10324
  year: 2022
  ident: pone.0285737.ref006
  article-title: Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(22)00094-0
  contributor:
    fullname: SA Costa Clemens
– volume: 18
  start-page: 2091865I
  issue: 6
  year: 2022
  ident: pone.0285737.ref020
  article-title: Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
  publication-title: Hum Vaccin Immunother
  doi: 10.1080/21645515.2022.2091865
  contributor:
    fullname: S Niyomnaitham
– volume: 103
  start-page: 115659I
  issue: 1
  year: 2022
  ident: pone.0285737.ref011
  article-title: Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
  publication-title: Diagn Microbiol Infect Dis
  doi: 10.1016/j.diagmicrobio.2022.115659
  contributor:
    fullname: J Van Elslande
– ident: pone.0285737.ref005
– volume: 11
  start-page: 100249I
  year: 2021
  ident: pone.0285737.ref007
  article-title: Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study
  publication-title: Lancet Reg Health Eur
  doi: 10.1016/j.lanepe.2021.100249
  contributor:
    fullname: P Nordström
– volume: 11
  start-page: e046676I
  issue: 10
  year: 2021
  ident: pone.0285737.ref016
  article-title: COVID-19 seroprevalence among hospital staff and preprocedural patients in Thai community hospitals: a cross-sectional study
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2020-046676
  contributor:
    fullname: T Nopsopon
– volume: 386
  start-page: 1910
  issue: 20
  year: 2022
  ident: pone.0285737.ref022
  article-title: Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2200674
  contributor:
    fullname: ED Moreira
– volume: 17
  start-page: e0263127I
  issue: 2
  year: 2022
  ident: pone.0285737.ref015
  article-title: Prevalences of SARS-CoV-2 RNA and anti-SARS-CoV-2 among at-risk populations in Chiang Mai and Lamphun provinces, Thailand, during November 2020–January 2021
  publication-title: PLOS ONE
  doi: 10.1371/journal.pone.0263127
  contributor:
    fullname: S Takalay
– volume: 72
  start-page: 254
  issue: 2
  year: 2021
  ident: pone.0285737.ref017
  article-title: Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciaa1116
  contributor:
    fullname: MP Busch
– volume: 136
  start-page: 104765I
  year: 2021
  ident: pone.0285737.ref028
  article-title: Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2021.104765
  contributor:
    fullname: J Van Elslande
– volume: 107
  start-page: 7
  year: 2023
  ident: pone.0285737.ref009
  article-title: Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies
  publication-title: Eur J Intern Med
  doi: 10.1016/j.ejim.2022.11.009
  contributor:
    fullname: H Alexopoulos
– volume: 386
  start-page: 1855
  issue: 19
  year: 2022
  ident: pone.0285737.ref021
  article-title: Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc2201821
  contributor:
    fullname: SK Yoon
– volume: 6
  start-page: 132I
  issue: 1
  year: 2021
  ident: pone.0285737.ref008
  article-title: Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination
  publication-title: NPJ Vaccines
  doi: 10.1038/s41541-021-00396-3
  contributor:
    fullname: R Assis
– volume: 10
  start-page: e0131522I
  issue: 5
  year: 2022
  ident: pone.0285737.ref010
  article-title: Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals
  publication-title: Microbiol Spectr
  doi: 10.1128/spectrum.01315-22
  contributor:
    fullname: B Grunau
– volume: 27
  start-page: 981
  issue: 6
  year: 2021
  ident: pone.0285737.ref019
  article-title: Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
  publication-title: Nat Med
  doi: 10.1038/s41591-021-01325-6
  contributor:
    fullname: JE Ebinger
SSID ssj0053866
Score 2.4742699
Snippet SARS-CoV-2 virus infection has imposed a significant healthcare burden globally. To contain its spread and decrease infection-related mortality, several...
SourceID plos
doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0285737
SubjectTerms Adult
Analysis
Antibodies
Antibodies, Viral
Biology and Life Sciences
Blood
Blood & organ donations
Blood Donors
Coronaviruses
COVID-19 - prevention & control
COVID-19 vaccines
Cross-Sectional Studies
Disease transmission
Evaluation
Female
Health aspects
Humans
Immune response
Immune system
Immunoglobulin G
Infection
Infections
Laboratories
Male
Medical research
Medicine and Health Sciences
Medicine, Experimental
Middle Aged
Mortality
Multivariate analysis
Nucleocapsids
Pandemics
Pharmaceutical industry
Proteins
SARS-CoV-2
Seroepidemiologic Studies
Serology
Severe acute respiratory syndrome coronavirus 2
Spike protein
Tertiary
Tertiary Care Centers
Thailand
Thailand - epidemiology
United Kingdom
United States
Vaccination
Vaccines
Variables
Viral antibodies
Viral diseases
Virus diseases
Viruses
SummonAdditionalLinks – databaseName: Open Access: DOAJ - Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBZlT72Upq-4eVQthbYQJWtLluTjJjSkhbaQTUJuRrKlrEmRl7U3EOiP78jWLusSaA-9esbCnpdm0OgbhN5zQ3UKmQWRhZaEFRkjSiQp0TEXwnArTYfT_e07P7tkX6_T641RX74nrIcH7gV3lDBeSpPBShlk7jrTKS0YZ4JmhRJl3COBjrNVMdXHYPBizsNFOSrio6CXw3ntzCHsqKnwc883NqIOr38dlUfzn3XzUMr5Z-fkxlZ0-hQ9CTkknvTfvoUeGfcMbQUvbfDHACX96Tn6NXFtRaaT8yk5qa9IgkGOla7Le9wNGcIblDtVFJWDzLPEdw2e101L-kYteNB1t-OydvWiwZXDCvtOgkot7vEszB05wMfK3dzWtwf4YqYq3y_5Al2efr44OSNh3gIpoAppidTSWDO2VFCtSqiaCxpbJhSzkBXZjJfg7TbWacmyRPJMMpVY7QEL_ZmwMjF9iUYOJLyNsKXg6yUEMAsVj5KlTpXOQGnxWDHNmIoQWQk_n_ewGnl3tiagHOmlmHtl5UFZETr2GlrzelDs7gGYSh5MJf-bqUTojddv3t8wXbt2PhEMqioP2R2hdx2HB8ZwvvPmRi2bJv_y4-ofmKbnA6YPgcnWYCmFCrcd4J884NaAc3fACe5dDMjb3hpXUmnyRELKRQUEU3hzZaEPk9-uyX5R303nTL3seDjsK1SOI_SqN-i1ZP3UIo9xFCE5MPWB6IcUV806XHKI7h7qKHn9P5S1gx4nkE_6Ro1Y7qJRu1iaPcj_Wr3fufpvarpVhg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELege-EFMb6WbYBBSIA0b0vi2M4TaqdNA4mB2m3aW2QnThsN2V3TTprEH885cUuDJsRr7tok9-W7-Pw7hN4zHasEMgsiciUIzVNKJI8SokLGuWal0A1O97czdnpBv14lV_6DW-3bKpcxsQnUhc3dN_KDSMBKE3Owoc_TG-KmRrndVT9C4yHaiKBSiHpoY3B89mO4jMXgzYz5A3MxDw-8fvan1uh9WFkT7uafry1IDW7_Kjr3pj9tfV_q-XcH5dqSdPIEPfa5JO63yt9ED7R5ija9t9b4o4eU_vQM_eqbeUVG_eGIHNlLEmGQZ6VscYebYUN4jXIr87wykIEW-LbGU1vPSduwBReaLndcWGNnNa4Mlth1FFRydocnfv7IHh5IM76213v4fCIr1zf5HF2cHJ8fnRI_d4HkUI3MiVBCl_qwjHmsZAHVcx6HJeWSlpAdlSkrwOvLUCUFTSPBUkFlVCoHXOj2hqUO4xeoZ0DCWwiXMfh8AYGshMpHikIlUqWUQ04pqaJUBogshZ9NW3iNrNlj41CWtFLMnLIyr6wADZyGVrwOHLu5YGfjzPtaFlFWCJ2C8aVQ7KlUJXFOGdw1zSUvQhqgN06_WXvSdOXiWZ9TqK4cdHeA3jUcDiDDuA6csVzUdfbl--V_MI2GHaYPnqm0YCm59Kce4J0c8FaHc7fDCW6ed8hbzhqXUqmzPw4Bv1xa6P3ktyuy-1PXVWe0XTQ8DNaXWBwG6GVr0CvJuulFDusoQKJj6h3RdymmmjT45BDlHeRRtP3v59pBjyLIGNvu0V3Um88W-hVkeHP12rvxb1w9Tsg
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdGeeEFMb6WMcAgJECaqyVxbOcBoW5iGkiAtG7T3iI7sdtoU1yadqISfzznxI0WVBCvvnM-znfnO_n8O4TeMB2rBCILInIlCM1TSiSPEqJCxrlmRugGp_vrN3ZyTr9cJpdbaN2z1Quw3pjauX5S5_Pr4c8fq49g8B-arg08XE8azmylh7BfJjzmd9DdyEFzuWI-2p0rgHUz5i_Q_W1mb4NqcPw7bz2YXdt6Uyj6Z0XlrS3q-AG672NLPGqVYRtt6eoh2vbWW-N3HmL6_SP0a1QtSjIenY7Jkb0gEQb5lsoWK9w0H8K3KDcyz8sKItIC39R4ZusFaQu4YKCpeseFrey8xmWFJXYVBqWcr_DU9yPZx4eymlzZq318NpWlq6N8jM6PP50dnRDfh4HkkJ0siFBCG31gYh4rWUA2ncehoVxSA9GSSVkBXsCEKiloGgmWCiojoxyQoTsrljqMn6BBBRLeQdjE4AMKcGwGMiEpCpVIlVIOMaakilIZILIWfjZr4Tay5syNQ5rSSjFzi5X5xQrQoVuhjteBZTcDdj7JvO1lEWWF0CkoYwrJn0pVEueUwVvTXPIipAF66dY3a2-ediafjTiFbMtBeQfodcPhADMqV5Ezkcu6zj5_v_gPpvFpj-mtZzIWNCWX_hYE_JMD4upx7vU4wezzHnnHaeNaKnUWCQjFYg5OFmauNXQz-VVHdg91VXaVtsuGh8F-E4uDAD1tFbqTrOtm5LCPAiR6qt4TfZ9SldMGrxy8voNAinb__V3P0L0IIkhXmhGKPTRYzJf6OUR8C_WiMeLfkpBTVw
  priority: 102
  providerName: Scholars Portal
Title Anti-SARS-CoV-2 antibody among SARS-CoV-2 vaccinated vs post-infected blood donors in a tertiary hospital, Bangkok, Thailand
URI https://www.ncbi.nlm.nih.gov/pubmed/37200273
https://www.proquest.com/docview/2815237051
https://search.proquest.com/docview/2816763380
https://pubmed.ncbi.nlm.nih.gov/PMC10194992
https://doaj.org/article/246d8e9cb89148b9b53c464739ca7d14
http://dx.doi.org/10.1371/journal.pone.0285737
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swELege9nLNPZFGOu8adI2ibQkcWznse3oYFIBtVDxFtlO0kZAUjUtEtL--J2dpGomHqa9uFLu0o_znX3X_Pw7hL7Q2JM-ZBY2V5LbRAXEFsz1belQxmKa8NjwdI_O6ek1-XXj3-wgWp-FMaB9JdNOdnffydK5wVYu7lW3xol1L0cDcCPNqeJ2d9EueGhdo5frL0QwpdUhOY853WpOOos8izuwm_pM9zzf2oQMV_9mRW4t7vLiqXTzb9Tk1jY0fIleVPkj7pXfcw_txNkrtFdFaIG_VTTS31-j371sldqT3nhiD_Kp7WKwYSrz6BGbBkN4S_IglEozyDoj_FDgRV6s7BKkBRcMsh1HeZYvC5xmWGCNIkjF8hHPq54jR7gvstltfnuEr-Yi1VjJN-h6eHI1OLWrXgu2ggpkZXPJ4yQ-TjzmSRFBxaw8JyFMkAQyoiSgEUR64kg_IoHLacCJcBOpyQr182ARO95b1MrAwvsIJx7EeQSLVwLVjuCR9IUMCIM8UhBJiLCQXRs_XJSUGqF5rsagFCmtGOrJCqvJslBfz9BGVxNimwv5chZWbhG6hEY8DsDhAijwZCB9TxEKnxoowSKHWOijnt-wPF26CeuwxwhUVJqu20KfjYYmxcg06mYm1kURnl1M_0FpMm4ofa2Ukhw8RYnqpAP8Jk221dA8bGhCaKuGeF97Y22VInQ5pFseg4UU7qw99Gnxp41Yv6lG0mVxvjY6FPYUjx9b6F3p0BvL6o5Fmt_IQrzh6g3TNyUQooaTvA7Jg_-_9T167kIGqaEZDj9ErdVyHX-AjG8l2xDmNwxGPnD0OPzZRs_6J-eXY3gdXEzPfrTNfykwjghvm-XgD-ImXMg
link.rule.ids 230,315,730,783,787,867,888,2109,2228,12070,12237,12779,21402,24332,27938,27939,31733,31734,33280,33281,33387,33388,33758,33759,38530,43324,43593,43614,43819,43909,53806,53808,74081,74350,74371,74638,74748
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLage4AXYNwWGMwgJECauyZxEucJdYWphV2ktav2FtlO0kZFcWnSSUP8eI4TtzTThBCvOacX25_PJT7-DkLv_MQVHkQWhEnBCJUhJTxwPCJsPwgSP2VJxdN9cur3L-jXS-_SvHArTFnlyiZWhjpWUr8jP3AYeBo3AAx9mv8gumuUPl01LTTuoi1wrB1A9VbvbDz4vLLFsJt931yYcwP7wKxPe67ypA2e1Qt0__MNh1Tx9q-tc2v-XRW3hZ43Kyg3XNLRQxStBlNXoszay1K05c8bPI__P9pH6IGJVnG3htc2upPkj9G2sQcF_mBIqz8-Qb-6eZmRYfd8SHpqTBwMK5YJFV_jqp0R3pBccSmzHGLcGF8VeK6KktQlYfCgqqPHscrVosBZjjnWNQsZX1zjqelwso8PeT6Zqdk-Hk15piszn6KLoy-jXp-Yzg5EQr5TEiZYkiad1A1cwWPIz6VrpzTgNIX4Kw39GOxKagsvpqHD_JBR7qRCUyPq02ee2O4z1MphDXcQTl2wKjGYyhRyK85i4XER0gCiVk4FpdxCZLW80bwm8IiqU7wAEp96FiMNh8jAwUKHGgNrXU2_XT1Qi0lkdnPkUD9mSQjwDiGdFKHwXEl9-NVQ8iC2qYX2NIKi-i7r2ohE3YBC_qbJwS30ttLQFBy5rvGZ8GVRRIOz8T8oDc8bSu-NUqoAi5KbexUwJk3t1dDcbWiCIZEN8Y7G-2pWiugPCOGTK5jeLn6zFusv1XV7eaKWlY4PHsxlHQs9r7fMemZ1fyTNpmQh1thMjalvSvJsWjGggx_RpErOi7__rz10rz86OY6OB6ffXqL7DsSnuvDDZruoVS6WySuIJ0vx2hiN3w30dKQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3rb9MwELegSIgvE-O1wGAGIQHSvC6JEzufUDeoNh4DrdvUb5adxG00FJemnTSJP55z4oYGTYivuevr3leff4fQ6zgPVQSVBeGp4oSmCSWSBRFRfsxYHmue1zjdX0_io3P6aRyN3fxT5cYqVzGxDtSZSe1_5P2AQ6YJGdhQX7uxiO8fhu9nP4ndIGVPWt06jdvoDqOQ6MC22bhtvsCv49hdnQuZ33ea2puZMt-DHBsxuwl9LTXVCP5tnO7NfpjqpiL071nKteQ0vI82XFWJB40ZbKJbefkAbTq_rfBbBy797iH6NSgXBRkNTkfk0FyQAINkC2Wya1yvHcJrlCuZpkUJtWiGryo8M9WCNKNb8KCed8eZKc28wkWJJbazBYWcX-Op20Syiw9kObk0l7v4bCoLO0H5CJ0PP54dHhG3gYGk0JcsCFc81_m-DlmoZAZ9dBr6mjJJNdRJOokz8H_tqyijScDjhFMZaGUhDO0pscz98DHqlSDhLYR1CN6fQUjT0ANJnqlIqoQyqC4lVZRKD5GV8MWsAdoQ9WkbgwalkaKwyhJOWR46sBpqeS1Mdv3AzCfCeZ0IaJzxPAEzTKDtU4mKwpTG8KlJKlnmUw_tWP2K5s5p6-xiwCj0WRbE20Ovag4LlVFao5vIZVWJ428X_8E0Ou0wvXFM2oClpNLdf4DfZCG4OpzbHU5w-LRD3rLWuJJKJf64BrxyZaE3k1-2ZPumdr6uzM2y5okh04R830NPGoNuJWv3GFnUIw_xjql3RN-llMW0RiqHeG_Bj4Kn__5eO-gu-LL4cnzy-Rm6F0AZaeczfL6Neov5Mn8OZd9Cvaj9-Te_pVSQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-SARS-CoV-2+antibody+among+SARS-CoV-2+vaccinated+vs+post-infected+blood+donors+in+a+tertiary+hospital%2C+Bangkok%2C+Thailand&rft.jtitle=PloS+one&rft.au=Permpikul%2C+Parichart&rft.au=Tongyoo%2C+Surat&rft.au=Chutikarn+Chaimayo&rft.au=Kanpai%2C+Prapan&rft.date=2023-05-18&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=18&rft.issue=5&rft.spage=e0285737&rft_id=info:doi/10.1371%2Fjournal.pone.0285737&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon